scholarly journals Case of Resistance to Thyroid hormones (RTH) with relatively rare mutation in Thyroid Hormones Receptor (THR)

Author(s):  
Hind Ahmed ◽  
Khalid Khamis ◽  
Mohanad Ahmed

This is an article that share clinical manifestation and diagnosis of patient with THR mutation, who found to have very rare mutation in THR-beta.

2018 ◽  
Vol 65 (8) ◽  
pp. 474-476
Author(s):  
María Guadalupe Guijarro de Armas ◽  
Carmen Pérez Blanco ◽  
Pablo Carrasco Lara ◽  
María Merino Viveros ◽  
Isabel Pavón de Paz

Medicina ◽  
2020 ◽  
Vol 56 (12) ◽  
pp. 699
Author(s):  
Maja Pajek ◽  
Magdalena Avbelj Stefanija ◽  
Katarina Trebusak Podkrajsek ◽  
Jasna Suput Omladic ◽  
Mojca Zerjav Tansek ◽  
...  

Resistance to thyroid hormone beta (RTHβ) is a syndrome characterized by a reduced response of target tissues to thyroid hormones. In 85% of cases, a pathogenic mutation in the thyroid hormone receptor beta (THRB) gene is found. The clinical picture of RTHβ is very diverse; the most common findings are goiter and tachycardia, but the patients might be clinically euthyroid. The laboratory findings are almost pathognomonic with elevated free thyroxin (fT4) levels and high or normal thyrotropin (TSH) levels; free triiodothyronin (fT3) levels may also be elevated. We present three siblings with THRB mutation (heterozygous disease-variant c.727C>T, p.Arg243Trp); two of them also had hypercholesterolemia, while all three had several other clinical characteristics of RTHβ. This is the first description of the known Slovenian cases with RTHβ due to the pathogenic mutation in the THRB gene. Hypercholesterolemia might be etiologically related with RTHβ, since the severity of hormonal resistance varies among different tissues and hypercholesterolemia in patients with THRB variants might indicate the relatively hypothyroid state of the liver. We suggest that cholesterol levels are measured in all RTHβ patients.


1984 ◽  
Vol 58 (6) ◽  
pp. 1188-1192 ◽  
Author(s):  
JAMES C. SISSON ◽  
NANCY J. HOPWOOD ◽  
SUE ELLYN SAUDER ◽  
BRAHM SHAPIRO

1978 ◽  
Vol 12 (11) ◽  
pp. 1101
Author(s):  
L DAVID ◽  
A ROUCHON ◽  
F CHATELAIN ◽  
R FRANCCIS

1981 ◽  
Vol 97 (3) ◽  
pp. 361-368 ◽  
Author(s):  
J. Salmerón De Diego ◽  
C. Alonso Rodriguez ◽  
A. Salazar Orlando ◽  
P. Sanchez Garcia Cervigon ◽  
E. Caviola Mutazzi ◽  
...  

Abstract. A 74 year old woman was found to have elevated serum thyroid-stimulating hormone (TSH) levels and elevated serum thyroid hormone levels, with clinical euthyroidism. There was no evidence of a pituitary tumour. TSH levels increased substantially during methimazole therapy. Administration of dexamethasone was followed by a prompt fall in serum TSH levels. Triiodothyronine (T3) was administered over a period of 20 days in doses from 25 μg to as much as 100 μg daily causing a rise in serum T3 above 700 ng/100 ml, a decline of T4 and a blunting of the response to thyrotrophinreleasing hormone (TRH), with normal metabolic responses (pulse rate, photomotogram, cholesterol). These results suggest that the patient's disorder is due to partial target organ resistance to thyroid hormones.


Sign in / Sign up

Export Citation Format

Share Document